Table: Wakamoto Pharm -Q1 parent results
Aug 3 (Reuters)-
Wakamoto Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2016 Jun 30, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.89 2.82 11.20
(+2.4 pct) (+7.8 pct) (+0.1 pct)
Operating 125 mln 126 mln 60 mln
(-1.0 pct) (+684.7 pct) (-27.9 pct)
Recurring 130 mln 144 mln 40 mln
(-9.6 pct) (-68.0 pct)
Net 85 mln 90 mln 2 mln
(-5.2 pct) (+164.9 pct) (-90.2 pct)
EPS 2.46 yen 2.59 yen 0.06 yen
Ann Div 3.00 yen
-Q2 div NIL
-Q4 div 3.00 yen
NOTE - Wakamoto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T
((Tokyo Headline News Desk +813 6441 1812))